Literature DB >> 9120662

Hypertension and stroke.

S Strandgaard1.   

Abstract

HYPERTENSION AND STROKE: Hypertension is a major risk factor for stroke, and stroke prevention is the most important achievement of modern antihypertensive treatment. In controlled trials, a few years of this treatment can eliminate the entire excess stroke risk associated with hypertension. In observational studies, stroke risk appears to be not always fully reversible when the blood pressure is lowered with drugs. Hypertension is associated with an increased incidence of both haemorrhagic, ischaemic and lacunar stroke. It is likely that antihypertensive treatment prevents all these types of strokes as well as transient ischaemic attacks. ACUTE STROKE: In acute stroke, a transient rise in blood pressure is common, in some cases superimposed on chronic hypertension. No major controlled trials have reported findings on whether blood pressure should be lowered acutely in such patients. On the basis of observational studies and haemodynamic considerations, it seems prudent to leave all but the highest blood pressures in acute stroke to settle spontaneously. ISCHAEMIC STROKE: Ischaemic stroke may occasionally be precipitated by overzealous blood pressure reduction. This has been reported in particular in the initial treatment of very severe hypertension, and occasionally in the elderly hypertensive. It may also occur in the rare cases where transient cerebral ischaemia is haemodynamically induced.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9120662     DOI: 10.1097/00004872-199610003-00005

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  11 in total

1.  Diagnosis and treatment of high blood pressure. New directions and new approaches: 1999 Canadian recommendations for management of hypertension.

Authors:  R J Petrella
Journal:  Can Fam Physician       Date:  2000-07       Impact factor: 3.275

2.  Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Authors:  Richard Sherva; Charles E Ford; John H Eckfeldt; Barry R Davis; Eric Boerwinkle; Donna K Arnett
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

3.  Blood pressure and cognition among older adults: a meta-analysis.

Authors:  Katherine A Gifford; Maria Badaracco; Dandan Liu; Yorghos Tripodis; Amanda Gentile; Zengqi Lu; Joseph Palmisano; Angela L Jefferson
Journal:  Arch Clin Neuropsychol       Date:  2013-07-09       Impact factor: 2.813

4.  Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

Authors:  R D Feldman; N R Campbell; P Larochelle
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

5.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

6.  CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Authors:  Eunhee Kim; Aaron T Tolhurst; Lu Ye Qin; Xin-Yuan Chen; Maria Febbraio; Sunghee Cho
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

7.  Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model.

Authors:  Barry J Connell; Bobby V Khan; Desikan Rajagopal; Tarek M Saleh
Journal:  Cardiol Res Pract       Date:  2012-01-04       Impact factor: 1.866

8.  Association of history of fracture with prehypertension and hypertension: a retrospective case-control study.

Authors:  Shuman Yang; Aimin Chen; Tianying Wu
Journal:  BMC Musculoskelet Disord       Date:  2015-04-12       Impact factor: 2.362

9.  Lipid profiles and ischemic stroke risk: variations by sex within racial/ethnic groups.

Authors:  Tefera Gezmu; Dona Schneider; Kitaw Demissie; Yong Lin; Christine Giordano; Martin S Gizzi
Journal:  Int J Womens Health       Date:  2014-05-30

10.  Probucol plus cilostazol attenuate hypercholesterolemia‑induced exacerbation in ischemic brain injury via anti-inflammatory effects.

Authors:  Ji Hyun Kim; Ki Whan Hong; Sun Sik Bae; Yong-Il Shin; Byung Tae Choi; Hwa Kyoung Shin
Journal:  Int J Mol Med       Date:  2014-07-10       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.